The socioeconomic burden of adult attention-deficit/hyperactivity disorder in Spain
Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non–small cell lung cancer in Spain
Costs of the Management of Hemophilia a with Inhibitors in Spain
Continuity of care between hospital pharmacies and community pharmacies, and costs avoided: a pilot experience in times of COVID-19 in Spain
A systematic review of economic evaluations in non-insulin antidiabetic treatments for patients with type 2 diabetes mellitus
The offset effect of pharmaceutical innovation: A review study
